Practice recommendations for Parkinson’s disease

Abstract

Get full access to this article

View all access options for this article.

References

Grimes

Gordon

Snelgrove

. Canadian guidelines on Parkinson’s disease. Can J Neurol Sci 2012;39(Suppl 4):S1-S30. Available: www.parkinsonclinicalguidelines.ca/sites/default/files/PD_Guidelines_2012.pdf (accessed Feb. 6, 2014).

Lang

Lozano

. Parkinson’s disease: first of two parts. N Engl J Med 1998;339:1044-53.

Guttman

Kish

Furukawa

. Current concepts in the diagnosis and management of Parkinson’s disease. CMAJ 2003;168:293-301.

arkinson’s Disease CNI (Aug. 18, 2013). Parkinson’s disease motor symptoms. Available: www.youtube.com/watch?v=3wg9ExKwZy4 (accessed Sept. 23, 2014).

Connolly

Lang

. Pharmacological treatment of Parkinson disease: a review. JAMA 2014;311:1670-83.

Patel

Chang

. Parkinson’s disease guidelines for pharmacists. Can Pharm J (Ott) 2014;147:161-70.

Van Gerpen

. Drug-induced parkinsonism. Neurologist 2002;8:363-70.

Shin

Chung

. Drug-induced parkinsonism. J Clin Neurol 2012;8:15-21.

López-Sendón

Mena

de Yébenes

. Drug-induced parkinsonism. Expert Opin Drug Saf 2013;4:487-96.

10.

Olanow

Stern

Sethi

. The scientific and clinical basis for the treatment of Parkinson disease. Neurology 2009;72(Suppl 4):S1-S136.

11.

Mynors

Jenkinson

MacNeill

. A pilot evaluation of specialist community pharmacy services for patients with Parkinson’s disease. Pharm J 2007;278:709-12.

12.

Schroder

Martus

Odin

. Impact of community pharmaceutical care on patient health and quality of drug treatment in Parkinson’s disease. Int J Clin Pharm 2012;34:746-56.

13.

Schroder

Martus

Odin

. Drug-related problems in Parkinson’s disease: the role of community pharmacists in primary care. Int J Clin Pharm 2011;33:674-82.